» Articles » PMID: 28658631

PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic Progenitors

Overview
Journal Cell Rep
Publisher Cell Press
Date 2017 Jun 29
PMID 28658631
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Pluripotent stem (PS)-cell-derived cell types hold promise for treating degenerative diseases. However, PS cell differentiation is intrinsically heterogeneous; therefore, clinical translation requires the development of practical methods for isolating progenitors from unwanted and potentially teratogenic cells. Muscle-regenerating progenitors can be derived through transient PAX7 expression. To better understand the biology, and to discover potential markers for these cells, here we investigate PAX7 genomic targets and transcriptional changes in human cells undergoing PAX7-mediated myogenic commitment. We identify CD54, integrin α9β1, and Syndecan2 (SDC2) as surface markers on PAX7-induced myogenic progenitors. We show that these markers allow for the isolation of myogenic progenitors using both fluorescent- and CGMP-compatible magnetic-based sorting technologies and that CD54+α9β1+SDC2+ cells contribute to long-term muscle regeneration in vivo. These findings represent a critical step toward enabling the translation of PS-cell-based therapies for muscle diseases.

Citing Articles

Multitasking muscle: engineering iPSC-derived myogenic progenitors to do more.

Hamer M, Rossi F Front Cell Dev Biol. 2025; 12:1526635.

PMID: 39911186 PMC: 11794491. DOI: 10.3389/fcell.2024.1526635.


Modulation of the JAK2-STAT3 pathway promotes expansion and maturation of human iPSCs-derived myogenic progenitor cells.

Caputo L, Stamenkovic C, Tierney M, Falzarano M, Bassel-Duby R, Ferlini A bioRxiv. 2024; .

PMID: 39713478 PMC: 11661153. DOI: 10.1101/2024.12.09.624203.


Generation of musculoskeletal cells from human urine epithelium-derived presomitic mesoderm cells.

Gao H, Huang X, Cai Z, Cai B, Wang K, Li J Cell Biosci. 2024; 14(1):93.

PMID: 39010176 PMC: 11251367. DOI: 10.1186/s13578-024-01274-w.


Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy.

Sun C, Serra C, Kalicharan B, Harding J, Rao M Cells. 2024; 13(7.

PMID: 38607035 PMC: 11011706. DOI: 10.3390/cells13070596.


The adult environment promotes the transcriptional maturation of human iPSC-derived muscle grafts.

Crist S, Azzag K, Kiley J, Coleman I, Magli A, Perlingeiro R NPJ Regen Med. 2024; 9(1):16.

PMID: 38575647 PMC: 10994941. DOI: 10.1038/s41536-024-00360-4.


References
1.
Cosgrove B, Gilbert P, Porpiglia E, Mourkioti F, Lee S, Corbel S . Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat Med. 2014; 20(3):255-64. PMC: 3949152. DOI: 10.1038/nm.3464. View

2.
Darabi R, Perlingeiro R . Derivation of Skeletal Myogenic Precursors from Human Pluripotent Stem Cells Using Conditional Expression of PAX7. Methods Mol Biol. 2014; 1357:423-39. DOI: 10.1007/7651_2014_134. View

3.
COOPER R, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne G . In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci. 1999; 112 ( Pt 17):2895-901. DOI: 10.1242/jcs.112.17.2895. View

4.
Sousa-Victor P, Gutarra S, Garcia-Prat L, Rodriguez-Ubreva J, Ortet L, Ruiz-Bonilla V . Geriatric muscle stem cells switch reversible quiescence into senescence. Nature. 2014; 506(7488):316-21. DOI: 10.1038/nature13013. View

5.
Quarta M, Brett J, DiMarco R, de Morree A, Boutet S, Chacon R . An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy. Nat Biotechnol. 2016; 34(7):752-9. PMC: 4942359. DOI: 10.1038/nbt.3576. View